Iliana Jaeger

Iliana Jaeger is a specialist in forensic investigations and financial crime. Ms. Jaeger brings more than 11 years of experience in managing high-profile matters covering both regulatory and internal investigations and litigations, mainly relating to fraud and corruption, including in relation to the Foreign Corrupt Practices Act (“FCPA”) and the Office of Foreign Assets Control (“OFAC”). She also has experience with investigations involving asset misappropriation, conflicts of interest, sanctions, market manipulation, data theft, confidentiality breach and money laundering.

Ms. Jaeger works with clients across various industries, including the life sciences, industrial products, financial services, retail and manufacturing industries. She leads domestic and international investigations and litigations in major locations around the world, such as Switzerland, Germany, India, Indonesia and the U.S., as well as the creation of innovative, technology-enabled investigation methodologies that leverage analytics and other technologies throughout the investigation lifecycle. Ms. Jaeger also advises international clients on compliance framework improvements and has led various FCPA compliance audits for several multinational pharmaceutical companies.

Prior to joining FTI Consulting, Ms. Jaeger was Director, Disputes and Investigations, at Alvarez & Marsal in Switzerland. She has also held digital forensics and investigations roles at multiple Big Four consulting firms.

Relevant Experience:

• Led various national and international large-scale investigations for multinational companies leveraging technology throughout investigation
• Served as leader in a conflicts of interest and fraud investigation of the Indian subsidiary of a global Swiss-based industrial products company, as well as of the U.S. subsidiary of a global Swiss-based pharmaceutical company
• Oversaw a fraud and corruption investigation of a global manufacturing company headquartered in Switzerland, including additional allegations of bribery of government officials and price collusion
• Led FCPA-focused compliance audits for multinational pharmaceutical companies with a subsidiary in Switzerland